Sleep Aids (Pharmacies) - Southern Europe

  • Southern Europe
  • Revenue in the Sleep Aids market is projected to reach US$356.00m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.21%, resulting in a market volume of US$397.20m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.50 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in Southern Europe is experiencing steady growth and development.

Customer preferences:
Customers in Southern Europe are increasingly seeking sleep aids to help them combat sleep disorders and improve their overall sleep quality. Factors such as high stress levels, busy lifestyles, and the prevalence of technology use before bed contribute to the growing demand for sleep aids. Additionally, the aging population in Southern Europe is also driving the need for sleep aids, as older individuals tend to experience more sleep disturbances.

Trends in the market:
One prominent trend in the Sleep Aids (Pharmacies) market in Southern Europe is the increasing popularity of natural and herbal sleep aids. Customers are becoming more conscious of the potential side effects of traditional sleep aids and are seeking alternatives that are perceived as safer and more natural. This trend is reflected in the growing sales of herbal sleep aids and the introduction of new products in this category. Another trend in the market is the rise of online sales channels for sleep aids. Customers in Southern Europe are increasingly turning to online platforms to purchase sleep aids due to the convenience and anonymity they offer. Online sales channels also provide customers with a wider range of product options and competitive pricing, further driving their popularity.

Local special circumstances:
Southern Europe has a rich cultural tradition of using natural remedies and herbal medicines, which influences customer preferences in the Sleep Aids (Pharmacies) market. Customers in this region are more inclined to trust and try natural sleep aids, which explains the growing demand for herbal products. Additionally, Southern Europe has a strong pharmacy sector, with pharmacies being the primary distribution channel for sleep aids. Pharmacies in this region are well-established and trusted by customers, providing a convenient and accessible avenue for purchasing sleep aids. The close relationship between customers and pharmacists also allows for personalized recommendations and advice, which further drives sales.

Underlying macroeconomic factors:
The Sleep Aids (Pharmacies) market in Southern Europe is also influenced by underlying macroeconomic factors. Economic stability and disposable income levels play a significant role in determining customer purchasing power and willingness to spend on sleep aids. As the economy improves and disposable income levels rise, customers are more likely to invest in sleep aids to improve their quality of life. Furthermore, the aging population in Southern Europe is expected to continue growing, which will contribute to the sustained demand for sleep aids. As individuals age, they are more likely to experience sleep disturbances and seek solutions to improve their sleep quality. This demographic trend will continue to drive the growth of the Sleep Aids (Pharmacies) market in Southern Europe. In conclusion, the Sleep Aids (Pharmacies) market in Southern Europe is developing due to customer preferences for natural sleep aids, the rise of online sales channels, the cultural preference for herbal remedies, the strong pharmacy sector, and underlying macroeconomic factors such as economic stability and an aging population.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)